Delivery Order SPE2DR25D2014-SPE2DR26FA2H8
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,276.80 to AmerisourceBergen Drug Corp for Risperdal 0.5 mg tablets (60-count) on October 27, 2025, with completion scheduled for October 28, 2025. This firm fixed-price delivery order represents a competitive, non-set-aside award with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $1,976.26 to AmerisourceBergen Drug Corp for the supply of Risperdal 0.5 mg tablets (60-count packages) under a firm fixed-price contract. The award, issued on January 9, 2026, with an ultimate completion date of January 12, 2026, represents a competitively awarded, non-set-aside purchase order for pharmaceutical supply to support federal medical procurement needs. The contractor will perform from its corporate office location in...
- The Defense Logistics Agency awarded a delivery order valued at $1,037.00 to AmerisourceBergen Drug Corp for the supply of Risperdal (risperidone) 0.5 mg tablets in a quantity of 60 tablets. The contract was awarded on September 24, 2025, with an ultimate completion date of September 25, 2025, utilizing firm fixed-price pricing with no set-aside designation. Performance of this delivery will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $4,361.07 to AmerisourceBergen Drug Corp for the supply of Risperdal 0.5 mg tablets (60 count) on January 8, 2026, with a completion date of January 9, 2026. This firm fixed-price, competitively awarded delivery order was issued from Conshohocken, Pennsylvania, where the vendor maintains its corporate office. The award carries no set-aside designation, indicating it was competed on a full and open basis. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,618.32 to AmerisourceBergen Drug Corp for the supply of Risperdal (risperidone) 0.5 mg tablets in a quantity of 60 units. This competitively awarded, non-set-aside contract is classified as a firm fixed-price delivery order with an ultimate completion date of December 31, 2025. AmerisourceBergen will perform this delivery from its corporate office location in Conshohocken, Pennsylvania. This award represents a child...
- The Defense Logistics Agency's Medical Supply Chain awarded a $2,130.74 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Risperdal 0.5 mg on September 19, 2025, with a completion date of September 22, 2025. This competitively awarded, non-set-aside contract reflects a firm fixed-price delivery order structure typical of the agency's pharmaceutical procurement operations. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a $3,855.14 delivery order to AmerisourceBergen Drug Corp for 60 tablets of Risperdal 0.5 mg on November 26, 2025, with an ultimate completion date of November 28, 2025. This non-set-aside delivery order utilizes firm fixed price terms and will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Risperdal 0.5 mg tablets (60 count) with a ceiling value of $3,787.60. This competitively awarded, firm fixed-price delivery order is set to be completed by August 7, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Risperdal (risperidone) 2 mg tablets in a 60-count configuration, valued at $1,396.10. This non-set-aside contract was competitively awarded on April 1, 2025, with an ultimate completion date of April 2, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract utilizes firm fixed price terms under a delivery order structure. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Risperdal 2 mg tablets in quantities of 60 units, with a ceiling value of $2,008.32. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for ultimate completion by September 16, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order...
- SPE2DR25D2014Indefinite Delivery Contract
- SPE2DR25D2014-SPE2DR26FA2H8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Risperdal 0.5 mg tablets (60-count) on January 13, 2026, with a ceiling value of $1,746.55 and ultimate completion date of January 14, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the awardee's Conshohocken, Pennsylvania facility. The contract represents a task order under AmerisourceBergen's parent company, Cencora, Inc.'s, larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2031, which serves as the comprehensive vehicle for supplying pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor within the federal medical supply chain, supplying a broad portfolio of medications and healthcare commodities across multiple therapeutic domains to military treatment facilities and other government healthcare systems. This delivery order for Risperdal, an antipsychotic medication used in psychiatric treatment, exemplifies the type of specialized pharmaceutical products routinely procured through the DLA's pharmaceutical prime vendor contracts to support the Defense Health Agency and other federal medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 1/12/26 |